Medicale Corp. financial data

Symbol
MCLE on OTC
Location
Wellington, FL
Fiscal year end
30 September
Latest financial report
10-K - Q3 2025 - 12 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.14% % -88%
Debt-to-equity -100% % 0.17%
Return On Equity 32% % -57%
Return On Assets -103530% % -183%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,920,000 shares 0%
Common Stock, Shares, Outstanding 5,920,000 shares 0%
Entity Public Float $489,600 USD
Common Stock, Value, Issued $592 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5,920,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5,920,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $33,493 USD -39%
Operating Income (Loss) $33,493 USD 39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $58,213 USD -55%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $41,153 USD 29%
Earnings Per Share, Basic -0.01 USD/shares 0%
Earnings Per Share, Diluted -0.01 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $0 USD -100%
Assets $0 USD -100%
Accounts Payable, Current $995 USD
Accrued Liabilities, Current $5,192 USD
Liabilities, Current $33,652 USD 117%
Liabilities $140,086 USD 41%
Retained Earnings (Accumulated Deficit) $216,998 USD -23%
Stockholders' Equity Attributable to Parent $140,086 USD -42%
Liabilities and Equity $0 USD -100%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,000 USD 64%
Net Cash Provided by (Used in) Financing Activities $10,000 USD -64%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 5,920,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0 USD -100%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $45,570 USD 23%
Deferred Tax Assets, Gross $45,570 USD 23%
Deferred Tax Assets, Operating Loss Carryforwards $217,001 USD 23%
Additional Paid in Capital $76,320 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $0 USD